Showing results (1-10 of 449) with videos related to
Sort By:
Pageof 45
European Journal of Internal Medicine|February 24, 2006
Low-density lipoprotein size and cardiovascular preventionManfredi Rizzo, Kaspar BerneisDiabetes/Metabolism Research and Reviews|November 3, 2006
Small, dense low-density-lipoproteins and the metabolic syndromeManfredi Rizzo, Kaspar BerneisInternational Journal of Cardiology|January 18, 2006
Should we measure routinely the LDL peak particle size?Manfredi Rizzo, Kaspar BerneisRecent Patents on Cardiovascular Drug Discovery|January 29, 2008
An update on the role of the quality of LDL in cardiovascular risk: the contribution of the universities of Palermo and ZurichManfredi Rizzo, Kaspar BerneisCurrent Medical Research and Opinion|May 24, 2007
The clinical significance of the size of low-density-lipoproteins and the modulation of subclasses by fibratesManfredi Rizzo, Kaspar BerneisCardiovascular Drugs and Therapy|June 16, 2006
The clinical relevance of low-density-lipoproteins size modulation by statinsManfredi Rizzo, Kaspar BerneisJournal of Atherosclerosis and Thrombosis|October 6, 2005
Lipid triad or atherogenic lipoprotein phenotype: a role in cardiovascular prevention?Manfredi Rizzo, Kaspar BerneisFuture Cardiology|October 7, 2009
Update on the role of the atherogenic lipoprotein phenotype in cardiovascular preventionManfredi Rizzo, Kaspar BerneisMedical Hypotheses|April 29, 2009
Therapy with noninvasive ventilation in patients with obstructive sleep apnoea: effects on atherogenic lipoprotein phenotypeRuzena Tkacova, Manfredi Rizzo, Kaspar BerneisAdvances in Therapy|July 31, 2007
Effects of statins, fibrates, rosuvastatin, and ezetimibe beyond cholesterol: the modulation of LDL size and subclasses in high-risk patientsManfredi Rizzo, Giovam Battista Rini, Kaspar BerneisPageof 45